Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Kleiven Biomekanikanalyser AB
AB
Active
Org 5591490924
Gammelgårdsvägen 56 Lgh 1303
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
—
EBITDA margin
—
+80% vs 2023
Equity ratio
17.4%
Financial strength
Net profit 2024
SEK -21K
+80% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
—
—
EBITDA
SEK -21K
+80%
Net profit
SEK -21K
+80%
Total assets
SEK 7K
-76%
Equity
SEK 1K
-93%
Employees
0
—
Company information
Legal name
Kleiven Biomekanikanalyser AB
Org number
5591490924
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
13 februari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Huvudskadeanalyser och biomekaniska olycksrekonstruktioner.
Contact
Address
Gammelgårdsvägen 56 Lgh 1303
Email
sveink@kth.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
—
Staff expenses
—
—
—
—
−0
EBITDA
−209
−162
−178
−102
−21
Depreciation & amort.
−38
−38
−38
—
—
EBIT
−247
−200
−216
−102
−21
Net financials
—
—
—
—
0
Profit before tax
−247
−200
−216
−102
−21
Tax
−0
−0
—
—
—
Net profit
−247
−200
−216
−102
−21
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
195
138
57
30
7
Equity
195
138
51
19
1
Long-term debt
0
0
—
—
—
Short-term debt
0
0
5
11
6
Total debt
—
—
5
11
6
Financial ratios
5-year trend
EBITDA margin
-2089300.0%
This company
15.8%
Market median
-13223518% vs market
2020
2024
Equity ratio
17.4%
This company
38.2%
Market median
-54% vs market
2020
2024
Return on equity
-1667.3%
This company
18.4%
Market median
-9161% vs market
2020
2024
Net profit margin
-2087400.0%
This company
8.1%
Market median
-25770470% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
4.75×
This company
0.62×
Market median
-666% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
XL
Xiaogai Li
Deputy Board Member
2022
SB
Silvia Botero Kleiven
Board of Directors
2022
SK
Svein Kleiven
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Kleiven Biomekanikanalyser AB also hold positions in
0
other companies.
Person
Role here
Other companies
Xiaogai Li
Deputy Board Member
0 companies
Silvia Botero Kleiven
Board of Directors
0 companies
Svein Kleiven
Chairman
0 companies